Clinical Trail/MUHS/ICMR/Any other

Sr. No Title of research project Name of Principle investigator Sanctioning/ Collaborating agency Completed/Ongoing
1 A phase IV, prospective, multi – centric, double – blind, comparative, clinical study to compare the efficacy and safety of intravenous ulinastatin versus placebo along with standard supportive care in subjects with severe sepsis. Dr. Neelima Chafekar Bharat Serums & Vaccines Limited Complete
2 A Prospective, Multi – Centre, Double – blind, Randomized. Trial of Saroglitazar 4 mg versus placbo in patients with Alcoholic liver disease Dr. Soham Doshi Zydus Cadila Ongoing
3 “A prospective, multi – centre, double – blind, randomized, study to evaluate the safety and efficacy of Saroglitazar 4 mg versus Placeo in the treatment of HIV associated lipodystrophy.” Dr. Sandip Chaudhari Zydus Cadila Ongoing
4 “A multi – centric, prospective, randomized, double blind study to evaluate the safety and efficacy of Saroglitazar (LipaglynTM) 2 and 4 mg as compared to Fenofibrate, 160 mg in patients with dyslipidemia:. Dr. Sandip Chaudhari Zydus Cadila Ongoing
5 “A multi – centric, Prospective, Randomized Double – blind. Study of Evaluate the Safety and Efficacy of Saroglitazar  2 and 4 mg as Compared to Pioglitazone in Type 2 Diabetes Mellitus.” Dr. Jitendra Kodilkar Zydus Cadila Ongoing